Management of Multiple Bilateral Pulmonary Nodules
Initial Evaluation
- The American College of Radiology suggests that each nodule should be evaluated individually rather than assuming all are metastatic disease, as studies show that many additional nodules found during evaluation are benign (>85% in some studies) 1, 2
- The presence of numerous bilateral nodules up to 13 mm in size with a radiologic report suggesting metastatic disease requires prompt action rather than watchful waiting 3
- Nodules >8 mm require more aggressive evaluation compared to smaller nodules, and with multiple nodules measuring up to 13 mm, tissue diagnosis is warranted 4
Diagnostic Approach
- Review any prior imaging studies to assess for interval growth or change in nodule characteristics, as recommended by the American College of Radiology 3
- Order PET-CT scan to help characterize the nodules, as this has approximately 97% sensitivity for nodules ≥1 cm, according to the Journal of the American College of Radiology 3
- Arrange for pulmonology consultation within 1-2 weeks for bronchoscopic or CT-guided biopsy planning, as suggested by the American College of Chest Physicians 6
Tissue Diagnosis
- Percutaneous lung biopsy is rated as "usually appropriate" (8/9) for suspicious pulmonary nodules of this size, according to the American College of Radiology 3
- Target the most accessible nodule or the one with highest FDG uptake on PET scan for biopsy, as recommended by the American College of Radiology 3
- Do not deny potential curative treatment based solely on imaging findings without histopathological confirmation of metastasis, as suggested by the American College of Chest Physicians 4, 2
Management Algorithm
- Within 1 week, order PET-CT scan and refer to pulmonology, as recommended by the American College of Radiology 3, 6
- Within 2-3 weeks, obtain tissue diagnosis via CT-guided percutaneous biopsy or bronchoscopy with biopsy, as suggested by the American College of Radiology 3, 5
- After tissue diagnosis, refer to oncology for systemic therapy evaluation if metastatic disease, or to thoracic surgery and/or radiation oncology for treatment planning if primary lung cancer, as recommended by the American College of Chest Physicians 6